Correlation of Circulating Complement Levels with Clinical Characteristics of Patients with Diabetic Retinopathy
Guangjiang Wang,Yuan Guo
DOI: https://doi.org/10.2147/ijgm.s483571
IF: 2.145
2024-11-28
International Journal of General Medicine
Abstract:Guangjiang Wang, Yuan Guo Department of Ophthalmology, The Fourth Hospital of Baotou, Baotou City, Inner Mongolia Autonomous Region, 014030, People's Republic of China Correspondence: Yuan Guo, Department of Ophthalmology, The Fourth Hospital of Baotou, No. 1, Aogen Road, Qingshan District, Baotou City, Inner Mongolia Autonomous Region, 014030, People's Republic of China, Email Background: Type 2 diabetes mellitus (T2DM) is associated with diabetic retinopathy (DR). The complement system maintains the normal physiologic microenvironment of the retina. The relationship between serum complement levels and clinical features of DR remains unclear. Methods: Clinical characteristics of 252 patients with T2DM including 101 with non-DR (NDR), 79 with nonproliferative DR (NPDR), and 72 with proliferative DR (PDR) were prospectively analyzed. Serum complement levels were compared between NDR and DR patients. The correlation between clinical characteristics and complement levels in DR patients was analyzed. A multifactorial logistic analysis was constructed to predict the risk of developing DR in T2DM. Results: Serum C4, CFB, CFI, C3 and C5 levels were higher in DR patients than in NDR patients (all P < 0.05). In T2DM patients, C3 and C4 levels were higher in PDR patients than in DR patients (all P < 0.05), and MBL levels were not statistically different between the two cohorts ( P > 0.05). These complement components or fragments were positively correlated with the duration of diabetes, glycosylated hemoglobin (HbA1c), and triglycerides (TG) (all P < 0.05). C3, C5, the duration of diabetes, HbA1c, and TG were the independent risk factors for DR in T2DM patients. The ROC model showed good value for predicting the risk of developing DR in T2DM with an area under the curve of 0.887. Conclusion: Serum complements C3 and C5 are predictive factors for DR in patients with T2DM. The prediction model constructed by the clinical characteristics of patients with T2DM and complement can better distinguish between NDR and DR, and can be used as a potential biomarker for assessing the risk of developing DR. Keywords: Complement system, diabetic retinopathy, clinical features, complement factors Diabetes mellitus (DM), the prevalence of which is increasing worldwide, is characterized by hyperglycemia and abnormal metabolism of glucose, fats, and proteins due to insufficient insulin secretion and/or resistance. 1 DM patients often suffer from systemic and ocular health complications, including diabetic retinopathy and diabetic macular edema. 2 It is a common ocular microangiopathy in people with type 2 diabetes mellitus (T2DM), which can result in irreversible blindness. 3 The global prevalence of DM among people aged 20–79 years is 536.6 million in 2021, and will rise to 783.2 million in 2045. 4 Growing evidence suggests a connection between the complement system and inflammatory states, pinpointing it as a key element in inflammatory disorders. 5 Evidently, interactions with complement systems trigger various inflammatory reactions and are initiated via three primary pathways (classical, alternative, and lectin). 6 The classical pathway starts with binding between C1q and antibody, followed by cleavage of C2 and C4 by the C1 complex and synthesis of C3 convertase. The alternative pathway, also known as the bypass pathway, which transgresses C1, C4, and C2 and activates C3 directly, with the involvement of different factors to form C3 convertase. The lectin pathway, also known as the mannose-binding lectin (MBL) pathway, is activated by the interaction of MBL with mannose-containing polysaccharides found on the surface of microorganisms to cleave C4 and C4 and synthesize C3 invertase. 7 A key step in complement activity is the formation of C3 convertase, which cleaves C3 into C3a and C3b. 8,9 This step is the common confluence of the three pathways and initiates the effector function of the complement system. Studies have shown that complement is associated with ocular pathologies, including age-related macular degeneration, uveitis, and glaucoma. 10–12 In age-related macular degeneration, inhibition of C3a, C5a, CFB, and MAC or administration of the complement regulatory molecules CD59 and CFH prevents choroidal neovascularization in animal models. 13 Complement activator-inhibiting agents to experimental uveitis rats suppresses the expression of ocular swelling inflammatory factors, C3 activators, and adhesion factors, thereby inhibiting experimental uveitis. 14 Further, polymorphisms in genes that encode complement, CFB, CFI, and its receptor, as well as C5 have been shown to contribute t -Abstract Truncated-
medicine, general & internal